Delivery Order SPE2DB20D2104-SPE2DB23FT18C

Award Date 4/20/23
Potential Completion Date 4/21/23
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Potassium Chloride Extended Release 10 MEQ Tablets in quantities of 500 per bottle. The contract has a ceiling value of $1,199.60 and a period of performance through August 25, 2023. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles, with a potential value of $1,217.67 and a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Potassium Chloride Extended Release 10 MEQ capsules. The contract has a ceiling value of $9,837.88 and a period of performance ending on September 23, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award, which is likely...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of potassium chloride extended-release 10 milliequivalent (mEq) tablets in 500-count bottles, with a firm fixed price of $1,698.87 and a completion date of July 31, 2024. This contract is not set aside for any specific small business category. As a large pharmaceutical supplier, Amerisourcebergen leverages its extensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,778 potassium chloride extended-release tablets in packages of 500. The contract has a ceiling value of $1,349.95 and a completion date of April 17, 2024. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,104.43 firm fixed-price delivery order is for the supply of 4560970833 potassium chloride extended-release 8 milliequivalent (MEQ) tablets in 500-count bottles. The contract has a performance period ending on May 18, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,312.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4557624443 - Potassium Chloride Extended Release 20 MEQ Tablets, 500-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 24, 2022. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,578.25, is for the delivery of potassium chloride extended-release 8 milliequivalent tablets in 500-count packages. The contract has a firm fixed-price pricing type and an ultimate completion date of October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The $1,391.28 firm-fixed-price delivery order has a completion date of September 15, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This federal contract award is for the delivery of Potassium Chloride Extended Release 8 MEQ Tablets in quantities of 500 per bottle. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,423.70 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FT18C
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560666133 - Potassium Chloride Extended Release 8 MEQ Tablets in 500-count bottles. The contract has a ceiling value of $1,883.42 and an ultimate completion date of April 21, 2023. This is not a set-aside contract.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 12:10 PM